These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8018130)

  • 1. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature.
    Farrar HC; Walsh-Sukys MC; Kyllonen K; Blumer JL
    Pediatr Infect Dis J; 1993 Aug; 12(8):688-91. PubMed ID: 8018130
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection.
    Waites KB; Sims PJ; Crouse DT; Geerts MH; Shoup RE; Hamrick WB; Duffy LB; Cassell GH
    Pediatr Infect Dis J; 1994 Apr; 13(4):287-93. PubMed ID: 8036045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants.
    Gouyon JB; Benoit A; Bétremieux P; Sandre D; Sgro C; Bavoux F; Beneton C; Badoual J
    Pediatr Infect Dis J; 1994 Sep; 13(9):840-1. PubMed ID: 7808866
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of erythromycin on respiratory colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants.
    Bowman ED; Dharmalingam A; Fan WQ; Brown F; Garland SM
    Pediatr Infect Dis J; 1998 Jul; 17(7):615-20. PubMed ID: 9686728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum.
    Bührer C; Hoehn T; Hentschel J
    Drugs; 2001; 61(13):1893-9. PubMed ID: 11708762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of erythromycin-resistant Ureaplasma urealyticum meningitis in a premature infant].
    Chung HY; Chung JW; Chun SH; Sung HS; Kim MN; Kim KS
    Korean J Lab Med; 2007 Feb; 27(1):46-9. PubMed ID: 18094550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of Ureaplasma urealyticum from low birth weight infants.
    Crouse DT; Reese JM
    J Pediatr; 1995 Mar; 126(3):502-3; author reply 503-4. PubMed ID: 7726967
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birth weight infants.
    Heggie AD; Jacobs MR; Butler VT; Baley JE; Boxerbaum B
    J Pediatr; 1994 Jun; 124(6):956-61. PubMed ID: 8201486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ureaplasma urealyticum in the cerebrospinal fluid of a premature infant.
    Hentschel J; Abele-Horn M; Peters J
    Acta Paediatr; 1993 Aug; 82(8):690-3. PubMed ID: 8374221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum.
    Mabanta CG; Pryhuber GS; Weinberg GA; Phelps DL
    Cochrane Database Syst Rev; 2003; (4):CD003744. PubMed ID: 14583992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin induced cardiovascular toxicity.
    Fichtenbaum CJ; Babb JD; Baker DA
    Conn Med; 1988 Mar; 52(3):135-6. PubMed ID: 3359772
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of very preterm infants with Mycoplasma/Ureaplasma airway colonization treated with josamycine.
    See H; Lachenaud J; Alberti C; Mariani-Kurkdjian P; Aujard Y; Baud O
    Acta Paediatr; 2010 Apr; 99(4):625-6. PubMed ID: 20055775
    [No Abstract]   [Full Text] [Related]  

  • 13. Ureaplasma urealyticum resistance to erythromycin: confirmed by clinical trial.
    Kundsin RB; Horne HW; Walter CW
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1864-5. PubMed ID: 1615998
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum.
    Ogasawara KK; Goodwin TM
    Am J Perinatol; 1997 Apr; 14(4):233-7. PubMed ID: 9259934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter study].
    Salcedo Abizanda S; Cabero Roura L; Andreu Domingo A; Lucaya Layret J; Perapoch López J; Casellas Caro M; Fernández Pérez F; Campins Martí M; Torán Fuentes N; Peguero Monforte G
    An Esp Pediatr; 1997 Jun; Spec No 1():73-7. PubMed ID: 9382274
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic considerations for Ureaplasma urealyticum infections in neonates.
    Waites KB; Crouse DT; Cassell GH
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S208-14. PubMed ID: 8399918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children.
    Gouyon JB
    J Pediatr Gastroenterol Nutr; 1992 Jan; 14(1):120. PubMed ID: 1573505
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythromycin, motilin, and meconium.
    Danielian P
    Am J Obstet Gynecol; 1992 Feb; 166(2):767-8. PubMed ID: 1536263
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of Ureaplasma urealyticum from low birth weight infants.
    Waites KB; Cassell GH; Duffy LB; Searcey KB
    J Pediatr; 1995 Mar; 126(3):502; author reply 503-4. PubMed ID: 7869217
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythromycin lactobionate toxicity in preterm neonates.
    Sims PJ; Waites KB; Crouse DT
    Pediatr Infect Dis J; 1994 Feb; 13(2):164-7. PubMed ID: 8190550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.